Department of Surgical Oncology

Permanent URI for this collectionhttp://10.0.2.71:4000/handle/123456789/295

Browse

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    Duplicated Ureter: A Rare Anatomical Variation Diagnosed Incidentally During Open Radical Hysterectomy for Carcinoma Endometrium and Avoidance of Mishappening: A Case Report
    (Springer, 2024-04-24) Shivangi Sundram; Sourabh Nandi
    This case report presents a rare anatomical variation known as double ureter, where a comprehensive unilateral duplication of the left ureter originating from a single renal tissue was incidentally discovered during staging laparotomy for CA endometrium. This congenital anomaly significantly heightens the possibility of unintentional damage to the ureter during surgeries involving the pelvic area. In summary, ensuring careful exposure of both ureters along with the continuous vigilance of surgeons remains pivotal for ensuring a secure surgical procedure.
  • No Thumbnail Available
    Item
    To study the survival analysis and recurrence pattern in women treated for breast cancer: Retrospective study, a tertiary cancer center experience from Sub‐Himalayan Region of India
    (Wiley, 2024-01-04) Shivangi Sundram; Sourabh Nandi; Anshika Arora; Sunil Saini
    Background: Breast cancer is a leading health concern in India, comprising 25% of female cancers with significant mortality. This study was conducted at the Cancer Research Institute in the Northern Sub‐Himalayan region of India from 2016 to 2021, evaluated 674 breast cancer cases to analyze factors that influence recurrence. Methodology: Retrospective clinical audit assessing patients’ survival outcomes using Kaplan–Meier curves and Cox proportional hazard regression. Factors including age, molecular subtype, TNM staging, and treatment modalities were evaluated. Results: Notable findings include a high occurrence of breast cancer in young patients (24.48% ≤ 40 years) and varying recurrence rates among molecular subtypes with human epidermal growth factor receptor 2 neu‐enriched (25.24%) and triple‑negative breast cancer (22.58%) being the most common. Advanced T and N stages, neoadjuvant chemotherapy, and the number of nodes dissected showed significant associations with higher recurrence rates. Conclusion: This study sheds light on survival and recurrence patterns in Northern Sub‐Himalayan breast cancer patients, emphasizing the need for tailored treatment strategies, comprehensive follow‐up care, with improved understanding of regional outcomes. These findings contribute valuable insights for optimizing patient care and improving survival rates in this region.